New horizons: NT-proBNP for risk stratification of patients with shock in the intensive care unit

por Hoffmann, Ursula, Borggrefe, Martin, Brueckmann, Martina
Publicado 2006

Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis?

por Hoffmann, Ursula, Brueckmann, Martina, Borggrefe, Martin
Publicado 2009

Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria

por Clemens, Andreas, Noack, Herbert, Brueckmann, Martina, Lip, Gregory Y. H.
Publicado 2014

Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analys...

por Lee, Sally, Monz, Brigitta U, Clemens, Andreas, Brueckmann, Martina, Lip, Gregory Y H
Publicado 2012

Alterations of leptin in the course of inflammation and severe sepsis

por Behnes, Michael, Brueckmann, Martina, Lang, Siegfried, Putensen, Christian, Saur, Joachim, Borggrefe, Martin, Hoffmann, Ursula
Publicado 2012

Dabigatran etexilate for thromboprophylaxis in over 5000 hip or knee replacement patients in a real-world clinical setting

por Rosencher, Nadia, Samama, Charles M., Feuring, Martin, Brueckmann, Martina, Kleine, Eva, Clemens, Andreas, Frostick, Simon
Publicado 2016

Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment

por Behnes, Michael, Bertsch, Thomas, Lepiorz, Dominic, Lang, Siegfried, Trinkmann, Frederik, Brueckmann, Martina, Borggrefe, Martin, Hoffmann, Ursula
Publicado 2014

Rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism

por Albisetti, Manuela, Schlosser, Arno, Brueckmann, Martina, Gropper, Savion, Glund, Stephan, Tartakovsky, Igor, Brandão, Leonardo R., Reilly, Paul A.
Publicado 2017

Anticoagulant Effects of Dabigatran in Paediatric Patients Compared with Adults: Combined Data from Three Paediatric Clinical Trials

por Maas, Hugo, Gropper, Savion, Huang, Fenglei, Stangier, Joachim, Tartakovsky, Igor, Brueckmann, Martina, Halton, Jacqueline M. L., Mitchell, Lesley G.
Publicado 2018

Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA‐REG OUTCOME

por Pellicori, Pierpaolo, Ofstad, Anne Pernille, Fitchett, David, Zeller, Cordula, Wanner, Christoph, George, Jyothis, Zinman, Bernard, Brueckmann, Martina, Lindenfeld, JoAnn
Publicado 2020

Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I

por Hoffmann, Ursula, Espeter, Florian, Weiß, Christel, Ahmad-Nejad, Parviz, Lang, Siegfried, Brueckmann, Martina, Akin, Ibrahim, Neumaier, Michael, Borggrefe, Martin, Behnes, Michael
Publicado 2015

Design of a prospective patient‐level pooled analysis of two parallel trials of empagliflozin in patients with established heart failure

por Packer, Milton, Butler, Javed, Filippatos, Gerasimos, Zannad, Faiez, Ferreira, Joao Pedro, Zeller, Cordula, Brueckmann, Martina, Jamal, Waheed, Pocock, Stuart J., Anker, Stefan D.
Publicado 2020

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction

por Butler, Javed, Packer, Milton, Filippatos, Gerasimos, Ferreira, Joao Pedro, Zeller, Cordula, Schnee, Janet, Brueckmann, Martina, Pocock, Stuart J, Zannad, Faiez, Anker, Stefan D
Publicado 2021

Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial

por Packer, Milton, Zannad, Faiez, Butler, Javed, Filippatos, Gerasimos, Ferreira, Joao Pedro, Pocock, Stuart J., Brueckmann, Martina, Zeller, Cordula, Hauske, Sibylle, Anker, Stefan D.
Publicado 2021

Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled

por Ferreira, João Pedro, Zannad, Faiez, Butler, Javed, Filippatos, Gerasimos, Pocock, Stuart J., Brueckmann, Martina, Steubl, Dominik, Schueler, Elke, Anker, Stefan D., Packer, Milton
Publicado 2022

Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure

por Packer, Milton, Butler, Javed, Zeller, Cordula, Pocock, Stuart J., Brueckmann, Martina, Ferreira, João Pedro, Filippatos, Gerasimos, Usman, Muhammad Shariq, Zannad, Faiez, Anker, Stefan D.
Publicado 2023

Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER‐like endpoint definitions

por Anker, Stefan D., Siddiqi, Tariq Jamal, Filippatos, Gerasimos, Zannad, Faiez, Ferreira, João Pedro, Pocock, Stuart J., Brueckmann, Martina, Zeller, Cordula, Packer, Milton, Butler, Javed
Publicado 2022

Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR‐Reduced

por Filippatos, Gerasimos, Anker, Stefan D., Butler, Javed, Farmakis, Dimitrios, Ferreira, João Pedro, Gollop, Nicholas D., Brueckmann, Martina, Iwata, Tomoko, Pocock, Stuart, Zannad, Faiez, Packer, Milton
Publicado 2022

Antithrombotic Treatment of Embolic Stroke of Undetermined Source RE-SPECT ESUS Elderly and Renally Impaired Subgroups

por Diener, Hans-Christoph, Sacco, Ralph L., Easton, J. Donald, Granger, Christopher B., Bar, Michal, Bernstein, Richard A., Brainin, Michael, Brueckmann, Martina, Brueckmann, Martina, Cronin, Lisa, Donnan, Geoffrey, Gdovinová, Zuzana, Grauer, Claudia, Kleine, Eva, Kleinig, Timothy J., Lyrer, Philippe, Martins, Sheila, Meyerhoff, Juliane, Milling, Truman, Pfeilschifter, Waltraud, Poli, Sven, Reif, Michal, Rose, David Z., Šaňák, Daniel, Schäbitz, Wolf-Rüdiger
Publicado 2020

Rationale and design of the EMPERIAL‐Preserved and EMPERIAL‐Reduced trials of empagliflozin in patients with chronic heart failure

por Abraham, William T., Ponikowski, Piotr, Brueckmann, Martina, Zeller, Cordula, Macesic, Hemani, Peil, Barbara, Brun, Michèle, Ustyugova, Anastasia, Jamal, Waheed, Salsali, Afshin, Lindenfeld, JoAnn, Anker, Stefan D.
Publicado 2019